NCT04370834 2025-02-04Tocilizumab for Patients With Cancer and COVID-19 DiseaseNational Cancer Institute (NCI)Phase 2 Terminated1 enrolled 10 charts
NCT04358406 2023-11-28Rhu-pGSN for Severe Covid-19 PneumoniaBioAegis Therapeutics Inc.Phase 2 Completed64 enrolled 17 charts
NCT01502072 2021-02-15Respiratory Syncytial Virus - RSV ProtocolM.D. Anderson Cancer CenterPhase 2 Completed48 enrolled 11 charts